Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06074328 · ClinicalTrials.gov registry record · NA

Blended Reality Immersion for Geriatric Head Trauma: The BRIGHT Study

A NA study of Traumatic Brain Injury, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06074328: Completed NA study of Traumatic Brain Injury, sponsored by University of Maryland, Baltimore.

NCT06074328 is a NA study of Traumatic Brain Injury that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 30 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06074328, a NA study of Traumatic Brain Injury, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Traumatic brain injury (TBI) is a major public health concern, particularly among older adults (OAs) ≥ 65 years of age. Each year in the United States, TBI results in over 600,000 emergency department visits and hospitalizations among OAs. Mild TBI (mTBI) accounts for 80% of all TBI in OAs and is quite understudied in this rapidly growing population. mTBI, is mild in name only, as it can result in dysfunction in multiple cognitive domains, including attention, processing speed, executive functioning and memory and has been shown to be associated with progressive brain atrophy and increased susceptibility to neurodegenerative disorders. Cognitive rehabilitation therapy is an evidence-based approach that can successfully improve cognitive impairment following TBI. Virtual reality (VR) is emerging as a technology that can assess cognitive impairment and provide a neurorehabilitation modality (NRM) to improve cognitive decline post TBI. Not only can VR provide a variety of environments like those encountered in real life and be adapted to varying levels and types of cognitive disability, but it can also be used safely in a patient's home with minimal equipment. Yet, despite the promise of cognitive rehabilitation using VR among OAs, very few studies to date have assessed the efficacy of VR cognitive rehabilitation in TBI. The aim of this study is to assess the effect and collect data on the efficacy and feasibility of a virtual reality application as a neurorehabilitation modality on executive functioning (attention, immediate memory, and visual-spatial skills) in OAs with mTBI. The hypothesis is that The use of VR mediated cognitive exercises post mTBI will be associated with improved executive function at 6-weeks post-randomization compared to the control group.

Primary Outcome

individually administered test measuring attention, language, visuospatial/constructional abilities, and immediate and delayed memory. The SCORES range from 40-160 with a mean and standard deviation of 100 and 15. Higher score = better outcome

Conditions Studied

Interventions

  • DEVICE Virtual Reality Neurocognitive Exercises administered through an Oculus Headset

Study Locations (1)

Maryland

  • R Adams Cowley Shock Trauma Center - Baltimore

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-11-29
Est. Completion 2025-08-15
Phase NA
University of Maryland, Baltimore

560 total trials

What the finished NCT06074328 record still lists

NCT06074328 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality Neurocognitive Exercises administered through an Oculus Headset is the first listed.

NCT06074328 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06074328 about?

NCT06074328 is a clinical study titled "Blended Reality Immersion for Geriatric Head Trauma: The BRIGHT Study". Traumatic brain injury (TBI) is a major public health concern, particularly among older adults (OAs) ≥ 65 years of age. Each year in the United States, TBI results in over 600,000 emergency department visits and hospitalizations among OAs. Mild TBI (mTBI) accounts for 80% of all TBI in OAs and is qu...

What is the current status of trial NCT06074328?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-11-29. Estimated completion is 2025-08-15.

What conditions does trial NCT06074328 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT06074328?

The interventions under investigation include: Virtual Reality Neurocognitive Exercises administered through an Oculus Headset (DEVICE).

Who is sponsoring clinical trial NCT06074328?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06074328 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06074328's enrollment target sits among peer trials

30 139th of 171 higher than 29 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06074328, the US trial registry maintained by the National Library of Medicine. NCT06074328 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.